Innovation Pharmaceuticals Inc (IPIX)

[Orion Nebula]

It is news. And Leo may expand a bit on what we see on the slide. You can't get to second base if you don't make it to first and I think the news is about as good as one can expect at such a low dosage. The fact that the hematology markers are clean is just excellent, reinforcing the prospects of future dosing increases.